News | ESC | July 21, 2020

European Society of Cardiology Announces Late-Breaking Study Presentations at its 2020 Virtual Congress

The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest clinical science presentations in cardiology at the 2020 annual congress digital meeting. The meeting has gone virtual due to the ongoing pandemic. 

The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest clinical science presentations in cardiology at the 2020 annual congress digital meeting. The meeting has gone virtual due to the ongoing pandemic. 

The congress is planned for Saturday, Aug. 29, through Tuesday Sept. 1, 2020. Read more on ECS's move to a digital meeting.

ESC said the event will include live presentations and panel discussions. To find out more, visit the event website at https://www.escardio.org/Congresses-&-Events/ESC-Congress

Hot Line sessions below are all in Central European Summer Time (CEST):

Saturday, Aug. 29
   • Hot Line 1: EMPEROR-Reduced: Empagliflozin in Heart Failure With a Reduced Ejection Fraction, With and Without Diabetes. 14:30 - 15:00
   • Hot Line 2: EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy. 15:30 - 16:00
   • Hot Line 3: EAST – AFNET 4: Effects of Early Rhythm Control Therapy in Patients with Atrial Fibrillation. 17:00 - 17:30

 

Sunday, Aug. 30
   • Hot Line 4: ATPCI - Trimetazidine in Angina Patients with Recent Successful Percutaneous Coronary Intervention: a Randomized, Double-Blind, Placebo-Controlled Trial. 14:00 - 14:30
   • Hot Line 5: POPULAR TAVI -Aspirin With or Without Clopidogrel. 14:30 - 15:00
   • Hot Line 6: PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF. 16:30 - 17:00

 

 

Monday, Aug. 31
   • Hot Line 7: LoDoCo2 Low-Dose Colchicine in Coronary Disease. 14:00 - 14:30
   • Hot Line 8: HOME-PE - Hospitalisation or Outpatient Management of PE Patients - HESTIA vs. Simplified PESI. 14:30 - 15:00
   • Hot Line 9: BPLTTC - Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure. 16:30 - 17:00

 

Tuesday, Sept. 1
   • Hot Line 10: BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19. 14:00 - 14:30
   • Hot Line 11: IMPACT-Afib Implementation of Stroke Prevention in Atrial Fibrillation. 14:30 - 15:00
   • Hot Line 12: REALITY - A Trial of Transfusion Strategies for Myocardial Infarction and Anemia. 16:30 - 17:00

 

Other ESC Clinical Studies

Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation

Icosapent Ethyl Significantly Reduces Coronary Plaque in EVAPORATE Study
 

Read the article Highlights From the 2019 ESC Congress.
 


Related Content

News | Cardiovascular Clinical Studies

May 31, 2024 — CareDx, a leading precision medicine company focused on the discovery, development, and commercialization ...

Home May 31, 2024
Home
News | Cardiovascular Clinical Studies

May 29, 2024 — Data was presented by AstraZeneca on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL ...

Home May 29, 2024
Home
News | Cardiovascular Clinical Studies

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that ...

Home May 23, 2024
Home
News | Cardiovascular Clinical Studies

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings ...

Home May 23, 2024
Home
News | Cardiovascular Clinical Studies

May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging ...

Home May 21, 2024
Home
News | Cardiovascular Clinical Studies

May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have ...

Home May 20, 2024
Home
News | Cardiovascular Clinical Studies

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

Home May 18, 2024
Home
News | Cardiovascular Clinical Studies

May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results ...

Home May 17, 2024
Home
News | Cardiovascular Clinical Studies

May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the ...

Home May 15, 2024
Home
Subscribe Now